{
  "meta": {
      "profile": [
          "https://www.medizininformatik-initiative.de/fhir/core/modul-medikation/StructureDefinition/MedicationStatement"
      ]
  },
  "dosage": [
      {
          "doseAndRate": [
              {
                  "doseQuantity": {
                      "code": "mg/kg",
                      "system": "http://unitsofmeasure.org",
                      "unit": "mg/kilogram",
                      "value": 50
                  }
              }
          ],
          "route": {
              "coding": [
                  {
                      "code": "20045000",
                      "display": "Intravenous use",
                      "system": "http://standardterms.edqm.eu"
                  }
              ]
          },
          "text": "Doxorubicin (Caelyx) 50 mg je Quadratmeter Koerperoberflaeche alle vier Wochen per intravenoeser Tropfinfusion",
          "timing": {
              "repeat": {
                  "frequency": 1,
                  "period": 4,
                  "periodUnit": "wk"
              }
          }
      }
  ],
  "effectiveDateTime": "2020-01-14T11:37:00+01:00",
  "medicationReference": {
      "reference": "Medication/8b67be5c-d83a-417c-864e-85fb5e9f4d52"
  },
  "status": "active",
  "subject": {
      "reference": "Patient/688f4605-71c0-48ef-a2d8-cd03a6d3dee1"
  },
  "resourceType": "MedicationStatement"
}